Regeneron Pharmaceuticals (REGN) Change in Acquisitions & Divestments (2009 - 2026)

Regeneron Pharmaceuticals' Change in Acquisitions & Divestments history runs 18 years deep, the most recent figure standing at $2.6 billion for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 24.63% year-over-year to $2.6 billion; the TTM figure through Mar 2026 stood at $10.7 billion (down 25.49% YoY), while the FY2025 annual figure was $11.5 billion, down 23.17% from the prior year.
• Change in Acquisitions & Divestments was $2.6 billion for Q1 2026 at Regeneron Pharmaceuticals, up from $2.6 billion in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $4.3 billion in Q3 2024 to a low of $746.3 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $2.6 billion across 5 years, with a median of $2.6 billion in 2025.
• The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments jumped 383.46% in 2022, then plunged 46.53% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $1.5 billion in 2022, then surged by 55.0% to $2.4 billion in 2023, then grew by 8.36% to $2.6 billion in 2024, then dropped by 1.05% to $2.6 billion in 2025, then advanced by 2.02% to $2.6 billion in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $2.6 billion (Q1 2026), $2.6 billion (Q4 2025), and $3.4 billion (Q3 2025), per Business Quant data.